Daniel Fabricant (Tag Archives)
Subscribe to PricePlow's Newsletter and Daniel Fabricant Alerts
NMN, FDA, and the Supplement Industry’s Fight for Its Life (Updated 7/17/23)
Background: A battle is brewing between the dietary supplement industry and the FDA. It’s over the legal status of an ingredient known as NMN, a natural vitamin with powerful anti-aging potential. After a company followed the guidelines to get NMN acknowledged as a legal dietary ingredient, the FDA has gone back on its word,[…] Continue Reading →
Dan Fabricant (NPA): Why You Need to Show Up in Washington DC | Episode #100
https://blog.priceplow.com/podcast/dan-fabricant-npa-2023-washington-dc
For Episode 100 of the PricePlow Podcast, Ben and Mike flew to Washington D.C. for the Natural Products Association’s annual DC Fly-In Day on June 7, 2023. Fly-in days, also known as “lobby days”, bring individuals together to advocate with legislators and other officials on behalf of their shared interests.
So this was […]
Continue Reading →
FDA Announcement on CBD: We Need Help from Congress
On January 26th, 2023, the FDA made a major announcement regarding CBD (Cannabidiol), coming after years of deliberation, debate, and discussion. The gist of the message:
“We need help from Congress!”
View this post on InstagramFDA to Congress: We need more tools!
In a press release titled […]
Continue Reading →
2022 Supplement Industry Awards | Episode #079
It’s that time of year again — time for PricePlow’s 2022 Supplement Industry Awards. Mike and Ben sat down to review 2022, and then got into a batch of awards similar to what we did in the 2021 Supplement Industry Awards.
2022 brought some great new ingredient innovations, but also came with some heartbreaking […]
Continue Reading →
The NPA is Fighting Dick Durbin’s 2022 Supplement Bill (S.4090) | PPP #067
https://blog.priceplow.com/podcast/npa-vs-dick-durbin-s4090
On April 26, Senators Dick Durbin (IL) and Mike Braun (IN) proposed a bill titled Dietary Supplement Listing Act of 2022,[1,2] which would have serious ramifications on the way business and commerce is done in the dietary supplement industry.
We invited a powerhouse team of industry veterans and experts to discuss what this […]
Continue Reading →
Mahmoud ElSohly & Ikhlas Khan’s $2.3 Million FDA Tax Waste: Incomplete Results Published
This is part four of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
Given the rancid stench emanating from the previous two disastrous studies discussed on this blog (1. Mahmoud ElSohly and […]
Continue Reading →
The Ten (Actually 11!) Times DMAA was Found in Nature (in Geraniums)
One of the most pivotal parts of the DMAA Lawsuit between Hi-Tech Pharmaceuticals and the FDA is whether or not DMAA is found in nature. Specifically, is the stimulant (also known as 1,3 dimethylamylamine) a natural constituent of certain species of geranium flowers?
Thanks to the latest documents released in the case, as well […]
Continue Reading →
The 2016 FDA NDI Draft Guidance Document: How To Destroy The ENTIRE Dietary Supplement Industry in 102 Pages
Disclaimer: This article was co-authored by Bruce Kneller and Mike.
On August 12th 2016, the FDA published a new Draft Guidance Document for NDIs (New Dietary Ingredients), in the Federal Register. Since this document is 102 pages long, there is much to discuss.
TL;DRThe FDA’s proposal is nothing short of a multi-pronged attack […]
Continue Reading →
Eric Schneiderman’s Supplement Lab Tests: The REAL False Claims?
Update, May 8, 2018: The Attorney General behind this fiasco, Eric Schneiderman, has resigned after at least four accusations of extremely racist sexual abuse. Even crazier, his criminality was predicted by President Trump as far back as 2013.[Tweet] It is unclear where this GNC deal will lie after the smoke clears.
Updated March 30, […]
Continue Reading →
